الفهرس 
Maintaining Immunosuppressive MedicationOnly 14 pages are availabe for public view
 |  | from | 102 |  |  |
| | | from | 102 | | |
Abstract
The present results confirm that patients who return to dialysis after
kidney allograft failure have poorer hemodialysis quality metrics than
transplant-naïve dialysis incident patients in terms of anemia,
hyperphosphatemia, hypocalcemia, hypercreatininemia, hyperuremia and
hypoalbuminemia. This could result in part from a lesser use of appropriate
medication despite regular follow-up by a nephrologist.
Mortality among patients on dialysis therapy after primary graft
failure increases significantly relative to mortality among patients still
awaiting primary kidney transplantation .
Nephrology care before dialysis is important, and consistency of care
in the immediate six months before dialysis is a predictor of mortality
This information can be used for the counselling and prognostication
for kidney transplant recipients who fail their first kidney allografts, or to
develop different care protocols for transplant patients with chronic kidney
disease that may allow them to reach dialysis in a better condition. The
establishment of more comprehensive predialysis care among patients with
failing renal allografts may improve achievement of both practice guidelines and clinical outcomes.